First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis
PRS-080#22(一种铁调素拮抗剂)在健康志愿者和接受血液透析的慢性肾病患者中开展的首次人体I期研究
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0212023
Renders, Lutz; Budde, Klemens; Rosenberger, Christian; van Swelm, Rachel; Swinkels, Dorine; Dellanna, Frank; Feuerer, Werner; Wen, Ming; Erley, Christiane; Bader, Birgit; Sommerer, Claudia; Schaier, Matthias; Meurer, Karoline; Matis, Louis